The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

Joni K. Doherty, Chris Bond, Armando Jardim, John Adelman, Gail M. Clinton

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

HER-2/neu (erbB-2) encodes an 185-kDa orphan receptor tyrosine kinase that is constitutively active as a dimer and displays potent oncogenic activity when overexpressed. Here we describe a secreted protein of ≃68 kDa, designated herstatin, as the product of an alternative HER-2 transcript that retains intron 8. This alternative transcript specifies 340 residues identical to subdomains I and II from the extracellular domain of p185HER-2 followed by a unique C-terminal sequence of 79 aa encoded by intron 8. The recombinant product of the alternative transcript specifically binds to HER- 2-transfected cells with a KD of ≃14 nM and was chemically crosslinked to p185HER-2, whereas the intron encoded sequence alone also binds with high affinity to transfected cells and associates with p185 solubilized from cell extracts. The herstatin mRNA is expressed in normal human fetal kidney and liver, but is at reduced levels relative to p185HER-2 mRNA in carcinoma cells that contain an amplified HER-2 gene. Herstatin appears to be an inhibitor of p185HER-2, because it disrupts dimers, reduces tyrosine phosphorylation of p185, and inhibits the anchorage-independent growth of transformed cells that overexpress HER-2.

Original languageEnglish (US)
Pages (from-to)10869-10874
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number19
DOIs
StatePublished - Sep 14 1999

Fingerprint

ErbB-2 Receptor
Protein-Tyrosine Kinases
Introns
Genes
erbB-2 Genes
Messenger RNA
Receptor Protein-Tyrosine Kinases
Cell Extracts
Tyrosine
Phosphorylation
Carcinoma
Kidney
Liver
Growth
herstatin
Proteins

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. / Doherty, Joni K.; Bond, Chris; Jardim, Armando; Adelman, John; Clinton, Gail M.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 19, 14.09.1999, p. 10869-10874.

Research output: Contribution to journalArticle

Doherty, Joni K. ; Bond, Chris ; Jardim, Armando ; Adelman, John ; Clinton, Gail M. / The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. In: Proceedings of the National Academy of Sciences of the United States of America. 1999 ; Vol. 96, No. 19. pp. 10869-10874.
@article{c62839b3acb14a1b9d7ded375af7da10,
title = "The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor",
abstract = "HER-2/neu (erbB-2) encodes an 185-kDa orphan receptor tyrosine kinase that is constitutively active as a dimer and displays potent oncogenic activity when overexpressed. Here we describe a secreted protein of ≃68 kDa, designated herstatin, as the product of an alternative HER-2 transcript that retains intron 8. This alternative transcript specifies 340 residues identical to subdomains I and II from the extracellular domain of p185HER-2 followed by a unique C-terminal sequence of 79 aa encoded by intron 8. The recombinant product of the alternative transcript specifically binds to HER- 2-transfected cells with a KD of ≃14 nM and was chemically crosslinked to p185HER-2, whereas the intron encoded sequence alone also binds with high affinity to transfected cells and associates with p185 solubilized from cell extracts. The herstatin mRNA is expressed in normal human fetal kidney and liver, but is at reduced levels relative to p185HER-2 mRNA in carcinoma cells that contain an amplified HER-2 gene. Herstatin appears to be an inhibitor of p185HER-2, because it disrupts dimers, reduces tyrosine phosphorylation of p185, and inhibits the anchorage-independent growth of transformed cells that overexpress HER-2.",
author = "Doherty, {Joni K.} and Chris Bond and Armando Jardim and John Adelman and Clinton, {Gail M.}",
year = "1999",
month = "9",
day = "14",
doi = "10.1073/pnas.96.19.10869",
language = "English (US)",
volume = "96",
pages = "10869--10874",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

AU - Doherty, Joni K.

AU - Bond, Chris

AU - Jardim, Armando

AU - Adelman, John

AU - Clinton, Gail M.

PY - 1999/9/14

Y1 - 1999/9/14

N2 - HER-2/neu (erbB-2) encodes an 185-kDa orphan receptor tyrosine kinase that is constitutively active as a dimer and displays potent oncogenic activity when overexpressed. Here we describe a secreted protein of ≃68 kDa, designated herstatin, as the product of an alternative HER-2 transcript that retains intron 8. This alternative transcript specifies 340 residues identical to subdomains I and II from the extracellular domain of p185HER-2 followed by a unique C-terminal sequence of 79 aa encoded by intron 8. The recombinant product of the alternative transcript specifically binds to HER- 2-transfected cells with a KD of ≃14 nM and was chemically crosslinked to p185HER-2, whereas the intron encoded sequence alone also binds with high affinity to transfected cells and associates with p185 solubilized from cell extracts. The herstatin mRNA is expressed in normal human fetal kidney and liver, but is at reduced levels relative to p185HER-2 mRNA in carcinoma cells that contain an amplified HER-2 gene. Herstatin appears to be an inhibitor of p185HER-2, because it disrupts dimers, reduces tyrosine phosphorylation of p185, and inhibits the anchorage-independent growth of transformed cells that overexpress HER-2.

AB - HER-2/neu (erbB-2) encodes an 185-kDa orphan receptor tyrosine kinase that is constitutively active as a dimer and displays potent oncogenic activity when overexpressed. Here we describe a secreted protein of ≃68 kDa, designated herstatin, as the product of an alternative HER-2 transcript that retains intron 8. This alternative transcript specifies 340 residues identical to subdomains I and II from the extracellular domain of p185HER-2 followed by a unique C-terminal sequence of 79 aa encoded by intron 8. The recombinant product of the alternative transcript specifically binds to HER- 2-transfected cells with a KD of ≃14 nM and was chemically crosslinked to p185HER-2, whereas the intron encoded sequence alone also binds with high affinity to transfected cells and associates with p185 solubilized from cell extracts. The herstatin mRNA is expressed in normal human fetal kidney and liver, but is at reduced levels relative to p185HER-2 mRNA in carcinoma cells that contain an amplified HER-2 gene. Herstatin appears to be an inhibitor of p185HER-2, because it disrupts dimers, reduces tyrosine phosphorylation of p185, and inhibits the anchorage-independent growth of transformed cells that overexpress HER-2.

UR - http://www.scopus.com/inward/record.url?scp=0032850779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032850779&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.19.10869

DO - 10.1073/pnas.96.19.10869

M3 - Article

VL - 96

SP - 10869

EP - 10874

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -